A comparative analysis of recurrence risk predictions in ER+/HER2- early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast.

Aparna GundaMallikarjuna S EshwaraiahKiran GangappaTaranjot KaurManjiri M Bakre

Published in: Breast cancer research and treatment (2022)

Data shows the use of CAB in early breast cancer overall and specifically in NPI-MPG and PREDICT high-risk patients for making accurate decisions on chemotherapy use. CAB provided unbiased risk stratification across cohorts of various geographies with minimal impact by clinical parameters.

Keyphrases

early breast cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
electronic health record
high resolution
radiation therapy
machine learning
patient safety
mass spectrometry
estrogen receptor
free survival
artificial intelligence
rectal cancer
patient reported